Table 3.
Number of quotations for each concept code: injectable route of administration
| Quotations related to injectable route of administration for antiretroviral therapies | |||
|---|---|---|---|
| Positive | Neutral | Negative | |
| 1. Healthcare provider visits | 5 | 1 | 7 |
| 2. Pain | 2 | 6 | 4 |
| 3. Needles | 3 | 5 | 8 |
| 4. Strength of dosage | 0 | 4 | 1 |
| 5. Diversion | 0 | 0 | 0 |
| 6. Access | 2 | 0 | 3 |
| 7. Stockpiling | 0 | 0 | 2 |
| 8. Traveling | 6 | 0 | 3 |
| 9. Food requirements | 4 | 4 | 1 |
| 10. Number of pills/HIV | 0 | 0 | 0 |
| 11. Number of pills/other conditions | 0 | 0 | 0 |
| 12. Frequency of doses | 34 | 4 | 10 |
| 13. Schedule issues | 1 | 0 | 1 |
| 14. Control of dosing | 1 | 0 | 2 |
| 15. Adherence concerns | 6 | 0 | 2 |
| 16. Adherence reports | 0 | 0 | 0 |
| 17. Adherence strategies | 0 | 0 | 0 |
| 18. Storage issues | 0 | 0 | 0 |
| 19. Medication error potential | 0 | 0 | 0 |
| 20. Ingestion issues | 0 | 0 | 0 |
| 21. Privacy/confidentiality (stigma) | 1 | 0 | 0 |
| 22. Source of pride/control | 0 | 0 | 0 |
| 23. Visible reminder of HIV status or treatment | 3 | 0 | 0 |
| 24. Emotional impact | 7 | 1 | 6 |
| 25. Ease of use | 2 | 0 | 0 |
| 26. Convenience | 6 | 0 | 5 |
| 27. Unspecified preference | 7 | 0 | 0 |